Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Cheap Ozempic boom meets new concerns over GLP-1 drug risks As India opens the floodgates to low-cost semaglutide, emerging evidence raises fresh concerns about long-term risks and treatment discontinuation
The Phase 3 TRIUMPH programme (over 5,800 participants) is registrational, with the earliest projected regulator approvals expected in the late-20262027 window
Stobiecka, M., Krl, J., & Brodziak, A
doi: 10.1111/cas.14648 26 QiuJZhangTZhuXYangCWangYZhouNet al
All patients provided informed consent prior to commencement
This step is not optional
US$ 29.74
US$ 25.85
US$ 28.83
US$ 24.00
US$ 21.51
US$ 26.26
US$ 22.76
US$ 24.28
